Global Managed Access Program Cohort for Ligelizumab in CSU

Study of Efficacy and Safety of Ligelizumab in Chronic Spontaneous Urticaria Patients Who Completed a Previous Study With Ligelizumab

NCT04210843 ·Status: TERMINATED ·Phase: PHASE3

Dose-finding Study of QGE031 as add-on Therapy to Evaluate Efficacy and Safety in Patients With CSU

NCT02477332 ·Status: COMPLETED ·Phase: PHASE2

Study to Investigate the Efficacy and Safety of QGE031 in Adolescent Patients With Chronic Spontaneous Urticaria (CSU)

NCT03437278 ·Status: COMPLETED ·Phase: PHASE2

Global Managed Access Program Cohort for Remibrutinib in Adult Patients With Chronic Spontaneous Urticaria

NCT05170724 ·Status: AVAILABLE

Study of Efficacy and Safety of Ligelizumab in Adolescents and Adults With Chronic Inducible Urticaria Who Remain Symptomatic Despite Treatment With H1- Antihistamines

NCT05024058 ·Status: TERMINATED ·Phase: PHASE3

Efficacy and Safety of QGE031 (Ligelizumab) in Patients With Peanut Allergy

NCT04984876 ·Status: TERMINATED ·Phase: PHASE3

Ritlecitinib (PF-06651600) in Participants With Chronic Spontaneous Urticaria

NCT06795373 ·Status: WITHDRAWN ·Phase: PHASE2

A Study to Describe the Real-world Effectiveness, Safety and Patterns of Use of Dupilumab in Patients With Chronic Spontaneous Urticaria

NCT07316114 ·Status: RECRUITING

A Study of LY3454738 in Adults With Chronic Spontaneous Urticaria

NCT04159701 ·Status: TERMINATED ·Phase: PHASE2

A Study of Quilizumab Versus Placebo in Patients With Refractory Chronic Spontaneous Urticaria

NCT01987947 ·Status: COMPLETED ·Phase: PHASE2

Study of CM512 Injection in Subjects With Chronic Spontaneous Urticaria(CSU)

NCT07166211 ·Status: RECRUITING ·Phase: PHASE2

A Study to Learn About Ritlecitinib for the Potential Treatment of Chronic Spontaneous Urticaria in Adults.

NCT07219615 ·Status: RECRUITING ·Phase: PHASE2

An Extension Study of Long-term Efficacy, Safety and Tolerability of Remibrutinib in Chronic Spontaneous Urticaria Patients Who Completed Preceding Studies With Remibrutinib

NCT05513001 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

A Study of MTPS9579A in Participants With Refractory Chronic Spontaneous Urticaria

NCT05129423 ·Status: WITHDRAWN ·Phase: PHASE2

Long-term Extension Study of Ligelizumab in Food Allergy

NCT05678959 ·Status: TERMINATED ·Phase: PHASE3

Mepolizumab for the Treatment of Chronic Spontaneous Urticaria

NCT03494881 ·Status: COMPLETED ·Phase: EARLY_PHASE1

Long-term Efficacy and Safety Extension (LTE) Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria

NCT07256392 ·Status: RECRUITING ·Phase: PHASE3

Study of Remibrutinib (LOU064) Efficacy and Safety and Exploration of Its Mechanism of Action in Participants With Chronic Urticaria

NCT06865651 ·Status: RECRUITING ·Phase: PHASE2

Phase 2b Study of EVO756 in Adults With Moderate to Severe Chronic Spontaneous Urticaria (CSU)

NCT06873516 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Omalizumab in Chronic Spontaneous Urticaria Patients Non Responding to Initial Standard antihistaminE Treatment

NCT02550106 ·Status: COMPLETED ·Phase: PHASE4

A Phase 3 Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria

NCT06445023 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Real Life Use of Omalizumab in Chronic Urticaria

NCT04584190 ·Status: UNKNOWN

A Study to Explore the Efficacy and Safety of HWH486 in Adults With Chronic Spontaneous Urticaria

NCT06295302 ·Status: RECRUITING ·Phase: PHASE2

A Study Evaluating the Safety, Tolerability, and Efficacy of EVO756 in Adults With Chronic Inducible Urticaria

NCT06603220 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate the Long-term Safety and Efficacy of Fenebrutinib in Participants Previously Enrolled in a Fenebrutinib Chronic Spontaneous Urticaria (CSU) Study

NCT03693625 ·Status: TERMINATED ·Phase: PHASE2